-
PERMIT Guidelines for designing and implementing all Stages of Personalised Medicine Research
17 January 2025 – The ICPerMed Family project PERMIT (PERsonalised MedicIne Trials) has published new recommendations ensuring the robustness of personalised medicine research programmes, throughout the personalised medicine pipeline.
-
The Ministry of Higher Education and Scientific Research of Tunisia joins ICPerMed
07 November 2024 – ICPerMed welcomes the Ministry of Higher Education and Scientific Research (MHESR) as new member.
-
Webinar on Collaboration to Increase Patient Involvement in Personalised Medicine – Lessons from Nigeria, Hungary, and Perspective from Europe
21 October 2024 – On 29 October 2024, from 16:00 to 17:30h, the EU-Africa PerMed consortium in collaboration with From Testing to Targeted Treatments (FT3) organises a webinar that will explore practical strategies for improving patient involvement and shared decision-making in healthcare. Real-world case studies from Nigeria and Hungary will highlight how these initiatives are…
-
Draft Strategic Research and Innovation Agenda for Personalised Prevention
01 October 2024 – The first draft of the Strategic Research and Innovation Agenda (SRIA) for Personalised Prevention of the ICPerMed Family project PROPHET was presented to invited experts at the Nanna Svartz Auditorium, BioClinicum, in Stockholm.
-
New ICPerMed Chairs elected
12 July 2024 – The International Consortium for Personalised Medicine (ICPerMed) has elected three new chairs. Étienne Richer (Canada, CIHR Institute of Genetics) will serve as chair, while Raili Sillart (Estonia, Ministry of Social Affairs) and Rizwana Mia (South African Medical Research Council) will serve as vice-chairs. ICPerMed would like to thank its outgoing Chair,…
-
Policy Brief on ethical, legal, and social aspects (ELSA) in the cooperation between Europe and China
28 June 2024 –The Sino-EU PerMed project has published its second policy brief on ethical, legal, and social aspects (ELSA) in the cooperation between Europe and China in personalised medicine.
-
ICPerMed State of the Art Report 2023 published
01 March 2024 – The ICPerMed State of the Art Report 2023 is published and provides information about ICPerMed’s activities, EP PerMed as well as other initiatives and activities supporting personalised medicine development and implementation.
-
Report of the 5th ICPerMed Workshop ‘Advancing Personalised Medicine through Technology Development’ available
01 March 2024 – The 5th ICPerMed Workshop was dedicated to the latest developments in technology and innovation that are driving personalised medicine innovation. The workshop showcased achievements and experiences of researchers, clinicians, biotech and industry leaders, and thus provided insights on how to drive personalised medicine-related innovations in healthcare. Furthermore, examples of promising technologies,…
-
Challenges, Opportunities and Facilitators in Implementing Personalised Medicine
16 February 2024 – ICPerMed published three documents presenting a review of challenges and identified facilitators for personalised medicine implementation in healthcare practices formulated as recommendations.
-
PROPHET Survey on Personalised Prevention
26 January 2024 – To bridge the gap between the slower adoption of personalised prevention strategies compared to other approaches to personalised medicine, ICPerMed family member PROPHET invites stakeholders in personalised medicine to participate in a survey on the perceived barriers, challenges and enablers to the adoption of personalised prevention strategies in the EU and…
